Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE173755 |
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML-RARA in Acute Promyelocytic Leukemia
|
28 | Cameron Osborne | Dec 14, 2022 | ||||
GSE183281 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets
|
209 | Susu Zhang | Dec 14, 2022 | ||||
GSE183293 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [ATAC-Seq]
|
16 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE183294 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [ChIP-Seq]
|
10 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE183295 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [Cut & Run]
|
66 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE188668 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [ATAC-Seq II]
|
4 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE188671 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [Cut & Run II]
|
7 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE206814 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [Cut & Run III]
|
36 |
|
Susu Zhang | Dec 14, 2022 | |||
GSE206815 |
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and controls RNA polymerase pause release at select gene targets [ChIP-Seq II]
|
18 | Susu Zhang | Dec 14, 2022 | ||||
GSE215101 |
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML-RARA in Acute Promyelocytic Leukemia [APL PBMCs ATAC-seq]
|
2 | Cameron Osborne | Dec 14, 2022 |